IL17A and psoriasis: RORγ deficient mice show diminished Th17/IL-17 in vitro responses and are protected in several animal models of autoimmune inflammatory diseases, such as experimental autoimmune encephalomyelitis, T-cell-transfer-mediated colitis and psoriasis-like skin inflammation (18, 29, 30).